Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:12 pm Sale | 2024-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 10,575,363 8.500% | -346,533 (-3.17%) | Filing History |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 13,054,145 10.500% | -2,692,522 (-17.10%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT LLC | 12,649,728 9.990% | 2,964,649 (+30.61%) | Filing History |
| 2024-11-14 2:53 pm Purchase | 2024-09-30 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 10,921,896 9.800% | 3,940,520 (+56.44%) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 15,746,667 12.837% | 1,533,302 (+10.79%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT LLC | 9,685,079 9.990% | 1,531,520 (+18.78%) | Filing History |
| 2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | Vaxcyte, Inc. PCVX | VANGUARD GROUP INC | 8,452,371 8.880% | 1,838,705 (+27.80%) | Filing History |
| 2024-02-13 2:10 pm Purchase | 2023-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 6,981,376 7.300% | 1,007,237 (+16.86%) | Filing History |
| 2024-02-09 10:05 am Purchase | 2024-02-08 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 14,213,365 14.937% | 4,044,084 (+39.77%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 8,575,238 9.000% | 3,469,868 (+67.97%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT LLC | 8,153,559 9.990% | 4,287,751 (+110.91%) | Filing History |
| 2023-02-10 4:29 pm Sale | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | TPG GP A, LLC | 1,190,336 1.500% | -2,959,208 (-71.31%) | Filing History |
| 2023-02-10 4:14 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | Carlyle Group Inc. CG | 2,070,724 2.600% | 2,070,724 (New Position) | Filing History |
| 2023-02-10 12:06 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 5,974,139 7.600% | 1,727,475 (+40.68%) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 10,169,281 12.875% | 2,294,931 (+29.14%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Vaxcyte, Inc. PCVX | VANGUARD GROUP INC | 6,613,666 8.370% | 3,479,380 (+111.01%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 5,105,370 6.500% | 2,316,363 (+83.05%) | Filing History |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,789,007 5.000% | 11,960 (+0.43%) | Filing History |
| 2022-02-14 6:44 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Longitude Venture Partners II L.P. | 1,616,070 3.100% | 1,616,070 (New Position) | Filing History |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,183,716 7.900% | 14,998 (+0.36%) | Filing History |